Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333–366 (2006).
Google Scholar
Sebag, J. Vitreous and vision degrading myodesopsia. Prog. Retin. Eye Res. https://doi.org/10.1016/j.preteyeres.2020.100847 (2020).
Asakura, A. Histochemistry of hyaluronic acid of the bovine vitreous body by electronmicroscopy. Nippon Ganka Gakkai Zasshi 89, 179–191 (1985).
Google Scholar
Sebag, J. & Balazs, E. A. Morphology and ultrastructure of human vitreous fibers. Invest. Ophthalmol. Vis. Sci. 30, 1867–1871 (1989).
Google Scholar
Sebag, J. Floaters and the quality of life. Am. J. Ophthalmol. 152, 3–4.e1 (2011).
Webb, B. F., Webb, J. R., Schroeder, M. C. & North, C. S. Prevalence of vitreous floaters in a community sample of smartphone users. Int. J. Ophthalmol. 6, 402–405 (2013).
Zou, H., Liu, H., Xu, X. & Zhang, X. The impact of persistent visually disabling vitreous floaters on health status utility values. Qual. Life Res. 22, 1507–1514 (2013).
Wagle, A. M., Lim, W.-Y., Yap, T.-P., Neelam, K. & Au Eong, K.-G. Utility values associated with vitreous floaters. Am. J. Ophthalmol. 152, 60–65.e1 (2011).
Kim, Y.-K. et al. Psychological distress in patients with symptomatic vitreous floaters. J. Ophthalm. https://doi.org/10.1155/2017/3191576 (2017).
Milston, R., Madigan, M. C. & Sebag, J. Vitreous floaters: etiology, diagnostics, and management. Surv. Ophthalmol. 61, 211–227 (2016).
Sebag, J., Yee, K. M. P., Wa, C. A., Huang, L. C. & Sadun, A. A. Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile. Retina 34, 1062–1068 (2014).
Macherner, R. The development of pars plana vitrectomy: a personal account. Graefes Arch. Clin. Exp. Ophthalmol. 233, 453–468 (1995).
Holekamp, N. M., Shui, Y.-B. & Beebe, D. C. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am. J. Ophthalmol. 139, 302–310 (2005).
Kunimoto, D. Y. & Kaiser, R. S. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology 114, 2133–2137 (2007).
Tsai, W. F., Chen, Y. C. & Su, C. Y. Treatment of vitreous floaters with neodymium YAG laser. Br. J. Ophthalmol. 77, 485–488 (1993).
Google Scholar
Procedure guide: vitreous opacities. Ellex Medical Pty https://www.ellex.com/uploads/Ellex-Laser-Procedure-Guide-Vitreolysis-Opacities-VB0002H-A4-ELECTRONIC.pdf (2022).
Rockwell, B. A., Thomas, R. J. & Vogel, A. Ultrashort laser pulse retinal damage mechanisms and their impact on thresholds. Med. Laser Appl. 25, 84–92 (2010).
Delaney, Y. M., Oyinloye, A. & Benjamin, L. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye 16, 21–26 (2002).
Google Scholar
Koo, E. H., Haddock, L. J., Bhardwaj, N. & Fortun, J. A. Cataracts induced by neodymium–yttrium-aluminium-garnet laser lysis of vitreous floaters. Br. J. Ophthalmol. 101, 709–711 (2017).
Xiong, R., Xu, R. X., Huang, C., Smedt, S. D. & Braeckmans, K. Stimuli-responsive nanobubbles for biomedical applications. Chem. Soc. Rev. https://doi.org/10.1039/C9CS00839J (2021).
Xiong, R. et al. Comparison of gold nanoparticle mediated photoporation: vapor nanobubbles outperform direct heating for delivering macromolecules in live cells. ACS Nano 8, 6288–6296 (2014).
Google Scholar
Liu, J. et al. Repeated photoporation with graphene quantum dots enables homogeneous labeling of live cells with extrinsic markers for fluorescence microscopy. Light Sci. Appl. 7, 47 (2018).
Harizaj, A. et al. Photoporation with biodegradable polydopamine nanosensitizers enables safe and efficient delivery of mRNA in human T cells. Adv. Funct. Mater. 31, 2102472 (2021).
Google Scholar
Barras, A. et al. Carbon quantum dots as a dual platform for the inhibition and light-based destruction of collagen fibers: implications for the treatment of eye floaters. Nanoscale Horiz. https://doi.org/10.1039/D1NH00157D (2021).
Hua, D. et al. Bubble forming films for spatial selective cell killing. Adv. Mater. https://doi.org/10.1002/adma.202008379 (2021).
Ueno, N., Sebag, J., Hirokawa, H. & Chakrabarti, B. Effects of visible-light irradiation on vitreous structure in the presence of a photosensitizer. Exp. Eye Res. 44, 863–870 (1987).
Google Scholar
Filas, B. A., Zhang, Q., Okamoto, R. J., Shui, Y.-B. & Beebe, D. C. Enzymatic degradation identifies components responsible for the structural properties of the vitreous body. Invest. Ophthalmol. Vis. Sci. 55, 55–63 (2014).
Google Scholar
Sauvage, F. et al. Photoablation of human vitreous opacities by light-induced vapor nanobubbles. ACS Nano 13, 8401–8416 (2019).
Google Scholar
Ziefuss, A. R., Reich, S., Reichenberger, S., Levantino, M. & Plech, A. In situ structural kinetics of picosecond laser-induced heating and fragmentation of colloidal gold spheres. Phys. Chem. Chem. Phys. 22, 4993–5001 (2020).
Google Scholar
Pan, Y. et al. Size-dependent cytotoxicity of gold nanoparticles. Small 3, 1941–1949 (2007).
Google Scholar
Desmettre, T., Devoisselle, J. M. & Mordon, S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv. Ophthalmol. 45, 15–27 (2000).
Google Scholar
Burk, S. E., Da Mata, A. P., Snyder, M. E., Rosa, R. H. & Foster, R. E. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107, 2010–2014 (2000).
Google Scholar
Seitz, B. & Langenbucher, A. Lasers in ophthalmology. Lancet 356, S26 (2000).
Masse, F., Ouellette, M., Lamoureux, G. & Boisselier, E. Gold nanoparticles in ophthalmology. Med. Res. Rev. 39, 302–327 (2019).
Pereira, D. V. et al. Effects of gold nanoparticles on endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 53, 8036–8041 (2012).
Google Scholar
Chen, F., Si, P., Zerda, Adela, V. Jokerst, J. & Myung, D. Gold nanoparticles to enhance ophthalmic imaging. Biomater. Sci. 9, 367–390 (2021).
Google Scholar
Hayashi, A., Naseri, A., Pennesi, M. E. & de Juan, E. Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye. Jpn. J. Ophthalmol. 53, 249–256 (2009).
Google Scholar
Rodrigues, E. B., Meyer, C. H., Mennel, S. & Farah, M. E. Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina 27, 958–970 (2007).
Kwok, A. K. H., Lai, T. Y. Y., Yew, D. T. W. & Li, W. W. Y. Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am. J. Ophthalmol. 136, 223–230 (2003).
Wels, M., Roels, D., Raemdonck, K., De Smedt, S. C. & Sauvage, F. Challenges and strategies for the delivery of biologics to the cornea. J. Control. Release 333, 560–578 (2021).
Google Scholar
Del Amo, E. M. et al. Pharmacokinetic aspects of retinal drug delivery. Prog. Retin. Eye Res. 57, 134–185 (2017).
Käsdorf, B. T., Arends, F. & Lieleg, O. Diffusion regulation in the vitreous humor. Biophys. J. 109, 2171–2181 (2015).
Lapotko, D. Optical excitation and detection of vapor bubbles around plasmonic nanoparticles. Opt. Express 17, 2538–2556 (2009).
Google Scholar
Xiong, R. et al. Laser-assisted photoporation: fundamentals, technological advances and applications. Adv. Phys. X 1, 596–620 (2016).
Google Scholar
Lukianova-Hleb, E. et al. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles. ACS Nano 4, 2109–2123 (2010).
Google Scholar
Lukianova-Hleb, E. Y. et al. Hemozoin-generated vapor nanobubbles for transdermal reagent- and needle-free detection of malaria. Proc. Natl Acad. Sci. USA 111, 900–905 (2014).
Google Scholar
Palanker, D. Femtosecond lasers for ophthalmic surgery enabled by chirped-pulse amplification. N. Engl. J. Med. 379, 2267–2269 (2018).
American National Standard for Safe Use of Lasers ANSI Z136.1-2014 (Laser Institute of America, 2015); https://www.lia.org/store/product/ansi-z1361-2014-safe-use-lasers-electronic-version
